Thomas Colarusso

Bio-Ai Health, Inc. is an American company that is dedicated to advancing precision medicine through the use of their AI technology. The company's goal is to improve disease diagnosis and predict patient response to therapy. The company was founded by Thomas Colarusso and Alan Jerusalmi, with Thomas Colarusso serving as the CEO since incorporation.

Tripos, Inc. engages in the provision of drug discovery informatics products and services. The company was founded by Garland Marshall in 1979 and is headquartered in St. Louis, MO.

Part of NovoDynamics, Inc., Nonlinear Dynamics, Inc. manufactures software for information discovery services. The company is based in Ann Arbor, MI. The company was founded by Laurel Harmon. Nonlinear Dynamics was acquired by NovoDynamics, Inc. on March 19, 2001.

Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany.